Changes in HIV-1 RNA Plasma Level in Patients Treated with Foscarnet
- 1 January 1997
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 14 (1) , 79-80
- https://doi.org/10.1097/00042560-199701010-00013
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Antiviral Effects of Foscarnet and Ganciclovir Therapy on Human Immunodeficiency Virus p24 Antigen in Patients with AIDS and Cytomegalovirus RetinitisThe Journal of Infectious Diseases, 1995
- Foscarnet Decreases Human Immunodeficiency Virus RNAThe Journal of Infectious Diseases, 1995
- In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)The Journal of Infectious Diseases, 1991
- Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1989
- Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnetAntimicrobial Agents and Chemotherapy, 1989
- PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1986